Cargando…

Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody

B-cell depletive therapies have beneficial effects in patients suffering from rheumatoid arthritis. Nevertheless, the role of B cells in the pathogenesis of the disease is not clear. In particular, it is not known how the regeneration of the B-cell repertoire takes place. Two patients with active rh...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouzière, Anne-Sophie, Kneitz, Christian, Palanichamy, Arumugam, Dörner, Thomas, Tony, Hans-Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175025/
https://www.ncbi.nlm.nih.gov/pubmed/15987473
http://dx.doi.org/10.1186/ar1731
_version_ 1782124492641796096
author Rouzière, Anne-Sophie
Kneitz, Christian
Palanichamy, Arumugam
Dörner, Thomas
Tony, Hans-Peter
author_facet Rouzière, Anne-Sophie
Kneitz, Christian
Palanichamy, Arumugam
Dörner, Thomas
Tony, Hans-Peter
author_sort Rouzière, Anne-Sophie
collection PubMed
description B-cell depletive therapies have beneficial effects in patients suffering from rheumatoid arthritis. Nevertheless, the role of B cells in the pathogenesis of the disease is not clear. In particular, it is not known how the regeneration of the B-cell repertoire takes place. Two patients with active rheumatoid arthritis were treated with rituximab, and the rearranged immunoglobulin heavy-chain genes (Ig-V(H)) were analysed to follow the B-cell regeneration. Patient A was treated with two courses of rituximab, and B-cell regeneration was followed over 27 months by analysing more than 680 Ig-V(H )sequences. Peripheral B-cell depletion lasted 7 months and 10 months, respectively, and each time was accompanied by a clinical improvement. Patient B received one treatment course. B-cell depletion lasted 5 months and was accompanied by a good clinical response. B cells regenerated well in both patients, and the repopulated B-cell repertoire was characterised by a polyclonal and diverse use of Ig-V(H )genes, as expected in adult individuals. During the early phase of B-cell regeneration we observed the expansion and recirculation of a highly mutated B-cell population. These cells expressed very different Ig-V(H )genes. They were class-switched and could be detected for a short period only. Patient A was followed long term, whereby some characteristic changes in the V(H)2 family as well as in specific mini-genes like V(H)3–23, V(H )4–34 or V(H )1–69 were observed. In addition, rituximab therapy resulted in the loss of clonal B cells for the whole period. Our data show that therapeutic transient B-cell depletion by anti-CD20 antibodies results in the regeneration of a diverse and polyclonal heavy-chain repertoire. During the early phase of B-cell regeneration, highly mutated B cells recirculate for a short time period in both the patients analysed. The longitudinal observation of a single patient up to 27 months shows subtle intraindividual changes, which may indicate repertoire modulation.
format Text
id pubmed-1175025
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11750252005-07-14 Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody Rouzière, Anne-Sophie Kneitz, Christian Palanichamy, Arumugam Dörner, Thomas Tony, Hans-Peter Arthritis Res Ther Research Article B-cell depletive therapies have beneficial effects in patients suffering from rheumatoid arthritis. Nevertheless, the role of B cells in the pathogenesis of the disease is not clear. In particular, it is not known how the regeneration of the B-cell repertoire takes place. Two patients with active rheumatoid arthritis were treated with rituximab, and the rearranged immunoglobulin heavy-chain genes (Ig-V(H)) were analysed to follow the B-cell regeneration. Patient A was treated with two courses of rituximab, and B-cell regeneration was followed over 27 months by analysing more than 680 Ig-V(H )sequences. Peripheral B-cell depletion lasted 7 months and 10 months, respectively, and each time was accompanied by a clinical improvement. Patient B received one treatment course. B-cell depletion lasted 5 months and was accompanied by a good clinical response. B cells regenerated well in both patients, and the repopulated B-cell repertoire was characterised by a polyclonal and diverse use of Ig-V(H )genes, as expected in adult individuals. During the early phase of B-cell regeneration we observed the expansion and recirculation of a highly mutated B-cell population. These cells expressed very different Ig-V(H )genes. They were class-switched and could be detected for a short period only. Patient A was followed long term, whereby some characteristic changes in the V(H)2 family as well as in specific mini-genes like V(H)3–23, V(H )4–34 or V(H )1–69 were observed. In addition, rituximab therapy resulted in the loss of clonal B cells for the whole period. Our data show that therapeutic transient B-cell depletion by anti-CD20 antibodies results in the regeneration of a diverse and polyclonal heavy-chain repertoire. During the early phase of B-cell regeneration, highly mutated B cells recirculate for a short time period in both the patients analysed. The longitudinal observation of a single patient up to 27 months shows subtle intraindividual changes, which may indicate repertoire modulation. BioMed Central 2005 2005-04-01 /pmc/articles/PMC1175025/ /pubmed/15987473 http://dx.doi.org/10.1186/ar1731 Text en Copyright © 2005 Rouzière et al, licensee BioMed Central Ltd.
spellingShingle Research Article
Rouzière, Anne-Sophie
Kneitz, Christian
Palanichamy, Arumugam
Dörner, Thomas
Tony, Hans-Peter
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
title Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
title_full Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
title_fullStr Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
title_full_unstemmed Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
title_short Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
title_sort regeneration of the immunoglobulin heavy-chain repertoire after transient b-cell depletion with an anti-cd20 antibody
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175025/
https://www.ncbi.nlm.nih.gov/pubmed/15987473
http://dx.doi.org/10.1186/ar1731
work_keys_str_mv AT rouziereannesophie regenerationoftheimmunoglobulinheavychainrepertoireaftertransientbcelldepletionwithananticd20antibody
AT kneitzchristian regenerationoftheimmunoglobulinheavychainrepertoireaftertransientbcelldepletionwithananticd20antibody
AT palanichamyarumugam regenerationoftheimmunoglobulinheavychainrepertoireaftertransientbcelldepletionwithananticd20antibody
AT dornerthomas regenerationoftheimmunoglobulinheavychainrepertoireaftertransientbcelldepletionwithananticd20antibody
AT tonyhanspeter regenerationoftheimmunoglobulinheavychainrepertoireaftertransientbcelldepletionwithananticd20antibody